Hubertus von Baumbach (born 1967) is a German businessman who is the chairman and CEO of Boehringer Ingelheim, Germany's second largest pharmaceutical company.
[2] The son of Erich von Baumbach and Ulrike Boehringer, Hubertus von Baumbach is also a great-grandson of the company's founder Albert Boehringer.
[3] In November 2015, it was announced that Baumbach, who had been CFO, was appointed as chief executive, succeeding Andreas Barner in June 2016.
[4] Within his first six months, he launched the biggest acquisition in the company's history (an asset swap deal with French rival Sanofi), followed by a reorganization to give the group a more decentralized divisional structure.
[5] In his capacity at Boehringer Ingelheim, Baumbach was part of Chancellor Angela Merkel’s delegation on three state visits to China.